Vaxxinity, Inc. (VAXX)
OTCMKTS · Delayed Price · Currency is USD
0.0001
0.00 (0.00%)
Oct 2, 2026, 4:00 PM EST
Vaxxinity Market Cap
Vaxxinity has a market cap or net worth of $12.68 thousand as of October 5, 2026. Its market cap has decreased by -99.50% in one year.
Market Cap
12.68K
Enterprise Value
n/a
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
ChartMarket Cap Chart
Since November 11, 2021, Vaxxinity's market cap has decreased from 2.08B to 12.68K, a decrease of -100.00%. That is a compound annual growth rate of -91.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 12.68K | -66.67% |
| Dec 31, 2025 | 38.02K | -94.00% |
| Dec 31, 2024 | 633.74K | -99.41% |
| Dec 29, 2023 | 107.73M | -38.95% |
| Dec 30, 2022 | 176.48M | -74.91% |
| Dec 31, 2021 | 703.46M | -66.12% |
| Nov 11, 2021 | 2.08B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Scopus BioPharma | 16.83K |
| Bio-Path Holdings | 15.09K |
| IO Biotech | 14.39K |
| Windtree Therapeutics | 13.50K |
| NovAccess Global | 12.33K |
| ObsEva | 11.72K |
| Trevena | 11.51K |
| Syros Pharmaceuticals | 10.73K |